Thinking of Buying Gentex (GNTX)? Here's What You Need to Know.

Shares of Consumer Cyclical sector company Gentex moved -0.4% today, and are now trading at a price of $27.27. The mid-cap stock's daily volume was 705,565 compared to its average volume of 988,058. The S&P 500 index returned a -0.3% performance.

Gentex Corporation designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection products in the United States, Germany, Japan, Mexico, and internationally. The company is based in Zeeland and has 4,998 full time employees. Its market capitalization is $6,397,051,392. Gentex currently offers its equity investors a dividend that yields 1.8% per year.

9 analysts are following Gentex and have set target prices ranging from $26 to $35 per share. On average, they have given the company a rating of buy. At today's prices, GNTX is trading -12.03% away from its average analyst target price of $31 per share.

Over the last year, GNTX shares have gone down by -22.8%, which represents a difference of -2.9% when compared to the S&P 500. The stock's 52 week high is $36.65 per share and its 52 week low is $23.28. Although Gentex's average free cash flow over the last four years has been $375,834,784.7, they have been decreasing at an average rate of -15.5%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2021-12-31 362 -69 293 -28.94
2020-12-31 464 -52 413 -2.04
2019-12-31 506 -85 421 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS